Coherus Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	244	159	371	778	1,225	1,252
Market Cap Growth	76.17%	-57.13%	-52.31%	-36.55%	-2.13%	-0.83%
Enterprise Value	106	361	718	971	1,176	1,166
Last Close Price	1.63	1.38	3.33	7.92	15.96	17.38
PE Ratio	3.10	5.58	-	-	-	9.47
Forward PE	-	-	-	-	-	16.86
PS Ratio	0.88	0.60	1.44	3.68	3.75	2.63
PB Ratio	2.16	-1.20	-1.92	-5.66	12.54	4.46
P/TBV Ratio	6.36	-	-	-	13.02	4.51
P/FCF Ratio	-	-	-	-	-	8.52
P/OCF Ratio	-	-	-	-	-	8.12
EV/Sales Ratio	0.38	1.35	2.79	4.60	3.60	2.45
EV/EBITDA Ratio	-	-	-	-	-	7.32
EV/EBIT Ratio	-	-	-	-	-	7.46
EV/FCF Ratio	-	-	-	-	-	7.93
Debt / Equity Ratio	0.62	-2.26	-2.49	-3.50	4.29	1.48
Debt / EBITDA Ratio	-	-	-	-	-	2.57
Debt / FCF Ratio	-	-	-	-	-	2.84
Net Debt / Equity Ratio	-1.56	-1.31	-1.88	-2.10	0.02	-0.44
Net Debt / EBITDA Ratio	1.72	-1.94	-1.92	-1.14	-0.01	-0.78
Net Debt / FCF Ratio	1.52	-8.45	-2.08	-1.20	-0.05	-0.84
Asset Turnover	0.54	0.50	0.46	0.36	0.43	0.76
Inventory Turnover	4.88	1.77	3.14	1.83	1.41	1.39
Quick Ratio	1.19	0.88	1.14	2.17	3.27	4.79
Current Ratio	1.24	1.21	1.43	2.75	3.64	5.27
Return on Equity (ROE)	-	-	-	-	-151.62%	68.49%
Return on Assets (ROA)	-10.26%	-10.94%	-21.75%	-27.68%	-21.68%	15.63%
Return on Invested Capital (ROIC)	-	-89.73%	-120.38%	-204.79%	-205.76%	110.66%
Return on Capital Employed (ROCE)	-58.10%	-57.00%	-64.90%	-75.10%	-51.30%	22.50%
Earnings Yield	63.61%	17.93%	-64.15%	-37.52%	-23.43%	10.56%
FCF Yield	-37.02%	-12.86%	-47.16%	-31.01%	-3.16%	11.73%
Buyback Yield / Dilution	-2.22%	-21.95%	-21.30%	-2.89%	9.63%	-14.08%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q